“…Regardless of its potential therapeutic benefits, the lack of bioavailability, poor solubility, low absorption, rapid metabolism, high excretion rate, limited tissue distribution, and poor stability of the curcumin present significant challenges [45] . Nanoformulations of curcumin such as encapsulating in or binding with nanocarriers, or conjugating with PEG can solve the curcumin insolubility, increase its circulation time, and may also mitigate its disadvantages [40] , [46] . Encapsulating or binding with metal oxides such as TiO 2 , ZnO, Fe 3 O 4 , CeO 2 and CuO protects curcumin from hydrolysis and phagocytosis, leading to its improved aqueous contact, blood circulation, stability, and bioavailability [47] .…”